1Trapp BD, Peterson J, Ransohoff RM,et al. Axonal transaction in the lesions of multiple sclerosis. N Engl J Med, 1998, 338(5): 278.?A
2Waxman SG. Demyelinating disease-new pathological insights, new therapeutic targets. N Engl J Med, 1998, 338(2): 323.
3Yulin G, Robert I, Grossman. Magnetization-transfer histogram analysis of gray matter in relapsing-remitting multiple sclerosis. AJNR, 2001, 22 (3): 470.
4Alberto Cifelli, Marzena Arridge, Peter Jezzard, et al. Thalamic Neurodegeneration in Multiple Sclerosis. Ann Neurol, 2002, 52: 650.
5Bitsch A, Bruhn H, Vougioukas V, et al. Inflammatory CNS demyelination: histopathologic correlation with in vivo quantitative proton MR spectroscopy. AJNR, 1999, 20(9): 1617.
6Degaonkar MN, Khubchandhani M, Dhawan JK, et al. Sequential proton MRS study of brain metabolite changes monitored during a complete pathological cycle of demyelination and remyelination in a lysophosphatidyl choline (Lpc)-induced experimental demyelinating lesion model. NMR Biomed,2002, 15(4): 293.
7Brex PA, Gomez-Anson B, Parker GJ, et al. Proton MR spectroscopy in clinically isolated syndromes suggestive of multiple sclerosis. J Neurol Sci, 1999, 166(1): 16.
8Simone IL, Tortorella C, Federico F. The contribution of (1)H-magnetic resonance spectroscopy in defining the pathophysiology of multiple sclerosis. Ital J Neurol Sci, 1999, 20(5): 241.
9Simone IL, Tortorella C, Federico F, et al. Axonal damage in multiple sclerosis plaques: a combined magnetic resonance imaging and 1H-magnetic resonance spectroscopy study. J Neurol Sci, 2001, 182(2): 143.
10Kapeller P, Brex PA, Chard D, et al. Quantitative 1H-MRS imaging 14 years after presenting with a clinically isolated syndrome suggestive of multiple sclerosis. Mult Scler, 2002, 8(3):207.?A[17]
6Yulin G, Robert I, Gross man. Magnetization transfer histogram analysis of gray matter in relapsing remitting multiple sclerosis. AJNR, 2001,22 (3) : 470.
7Trapp BD, Ransohoff RM, Fisher E, et al. Axonal transaction in the lesions of multiple sclerosis. N Eng J Med, 1998,338: 278-285.
8Trapp BD, Ransohoff RM, Fisher E, et al. Neurodegeneration in Multiple Sclerosis: relations to nerological disability. Neuroscientist, 1999,5: 48-57.
9Bjartmar C, Kidd C, Ransohoff RM, et al. A real-time insight into disease progression and the role of axonal injury in multiple sclerosis. Arch Neurol, 2001,58: 65-70.
10De Stefano N, Narayanan S, Francis GS, et al. Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability. Arch Neurol, 2001,58: 65-70.
